Why Do Some Recovered Peripartum Cardiomyopathy Mothers Experience Heart Failure With a Subsequent Pregnancy?

被引:17
|
作者
Fett J.D. [1 ,2 ,4 ]
Shah T.P. [3 ]
McNamara D.M. [1 ]
机构
[1] Investigations of Pregnancy Associated Cardiomyopathy (IPAC), Peripartum Cardiomyopathy Network of North America (PCN), Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
[2] Department of Adult Medicine, Hospital Albert Schweitzer, Deschapelles
[3] Baylor College of Medicine, Houston, TX
[4] 2331 Mt. Hood Court SE, Lacey, 98503, WA
关键词
Biomarkers; Echocardiography; Heart failure; Outcomes; Peripartum cardiomyopathy; PPCM; Subsequent pregnancy;
D O I
10.1007/s11936-014-0354-x
中图分类号
学科分类号
摘要
After concerns about survival and recovery from peripartum cardiomyopathy (PPCM), the question commonly asked is, “Is it safe to have another pregnancy?” While important advances have been made in the past decade in the recognition and treatment of PPCM, we still do not know why some apparently recovered PPCM mothers have a relapse of heart failure in a subsequent pregnancy. Knowing that some risk for relapse is always present, careful monitoring of the post-PPCM pregnancy is currently the best way to enable earlier diagnosis with institution of effective evidence-based treatment. In that situation it is reassuring to observe that when a subsequent pregnancy begins with recovered left ventricular systolic function to echocardiographic ejection fraction ≥0.50, even with relapse, the response to treatment is good with much more favorable outcomes. On the other hand, beginning the subsequent pregnancy with echocardiographic ejection fraction <0.50 greatly increases the risk for less favorable outcomes. This article summarizes the current state of knowledge; addresses the important questions facing patients, their families, and caregivers; and identifies the need for a prospective multi-center study of women with post-PPCM pregnancies. The reality is that an estimated 10 % to 20 % of apparently recovered PPCM mothers are going to relapse in a post-PPCM pregnancy; but we do not yet know why. Nevertheless, the lowest risk for relapse is experienced by those who (1) recover to left ventricular ejection fraction 0.55 prior to another pregnancy; (2) have no deterioration of left ventricular ejection fraction after phasing out angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker treatment following recovery; and perhaps, (3) demonstrate adequate contractile reserve on exercise echocardiography. © 2014, Springer Science+Business Media New York.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers
    Fett, James D.
    Fristoe, Kane L.
    Welsh, Serena N.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (01) : 34 - 36
  • [2] Heart Failure and Pregnancy: Thinking Beyond Peripartum Cardiomyopathy
    Lindley, Kathryn J.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (02) : 153 - 156
  • [3] Intersection of Heart Failure and Pregnancy Beyond Peripartum Cardiomyopathy
    DeFilippis, Ersilia M.
    Haythe, Jennifer H.
    Walsh, Mary Norine
    Kittleson, Michelle M.
    CIRCULATION-HEART FAILURE, 2021, 14 (05) : 613 - 627
  • [4] Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy
    Mandal, Debasmita
    Mandal, Saroj
    Mukherjee, Dipankar
    Biswas, Subhash Chandra
    Maiti, Tapan Kumar
    Chattopadhaya, Nibedita
    Majumdar, Biswakes
    Panja, Manotosh
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (03) : 222 - 227
  • [5] Safety of Subsequent Pregnancy After Recovery From Peripartum Cardiomyopathy
    Elkayam, Uri
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (01) : 27 - 29
  • [6] Risk Stratification for Subsequent Pregnancy After Prior Peripartum Cardiomyopathy
    Davis, Esther
    Yucel, Evin
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (01)
  • [7] Risk Stratification for Subsequent Pregnancy After Prior Peripartum Cardiomyopathy
    Esther Davis
    Evin Yucel
    Current Treatment Options in Cardiovascular Medicine, 2021, 23 (1)
  • [8] Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
    Sliwa, Karen
    Petrie, Mark C.
    Hilfiker-Kleiner, Denise
    Mebazaa, Alexandre
    Jackson, Alice
    Johnson, Mark R.
    van der Meer, Peter
    Mbakwem, Amam
    Bauersachs, Johann
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (06) : 951 - 962
  • [9] Acute heart failure: is it peripartum cardiomyopathy or not?
    Bachelier-Walenta, Katrin
    Hilfiker-Kleiner, Denise
    Sliwa, Karen
    OBSTETRIC MEDICINE, 2013, 6 (01) : 42 - 44
  • [10] Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy
    Yameogo, Nobila Valentin
    Samadoulougou, Andre Koudnoaga
    Kagambega, Larissa Justine
    Kologo, Koudougou Jonas
    Millogo, Georges Rosario Christian
    Thiam, Anna
    Guenancia, Charles
    Zansonre, Patrice
    BMC CARDIOVASCULAR DISORDERS, 2018, 18